Skip to main content
Premium Trial:

Request an Annual Quote

GNI, Aukland UniServices to Map Breast Cancer, Melanoma Gene Networks

NEW YORK (GenomeWeb News) — GNI and Auckland UniServices today today said they will work together to map gene regulatory networks for melanoma and breast cancer.
According to the partners, the effort will also study how the networks are affected as patients respond to various anti-cancer drugs. GNI and UniServices will co-own the intellectual property resulting from the three-year collaboration and GNI will lead the effort to commercialize it, the companies said.
GNI, a Japanese biopharmaceutical company, will provide its technology and reagents to produce the gene networks. In addition, some data analysis will be done at GNI's Systems Pharmacology Research Institute in Fukuoka.
The collaboration is supported by grants from New Zealand Health Research Council's International Investment Opportunities Fund and New Zealand's Breast Cancer Research Trust.
Auckland UniServices is the commercial arm of the University of Aukland.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.